JSAM
RVMD icon

J. Safra Asset Management’s Revolution Medicines RVMD Stock Holding History

J. Safra Asset Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.2K Buy
81
+18
+29% +$2.63K ﹤0.01% 353
2026
Q1 		$6.13K Buy
63
+12
+24% +$1.21K ﹤0.01% 435
2025
Q4 		$4.06K Hold
51
– – ﹤0.01% 458
2025
Q3 		$2.38K Hold
51
– – ﹤0.01% 377
2025
Q2 		$1.88K Hold
51
– – ﹤0.01% 351
2025
Q1 		$1.8K Buy
51
+43
+538% +$1.75K ﹤0.01% 327
2024
Q4 		$345 Buy
+8
New +$404 ﹤0.01% 333

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

J. Safra Asset Management's RVMD Position: Q2 2026 in Review

J. Safra Asset Management increased its Revolution Medicines (RVMD) stake by 29% in Q2 2026, buying an estimated $2.63K and bringing the position to 81 shares worth $15.2K. The position accounts for ﹤0.01% of the portfolio, ranked #353.

J. Safra Asset Management first reported a position in RVMD in Q4 2024 and has held it in 7 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • J. Safra Asset Management held 81 shares of Revolution Medicines worth $15.2K as of Q2 2026.
  • J. Safra Asset Management bought 18 Revolution Medicines shares in Q2 2026, an estimated $2.63K.
  • Revolution Medicines made up ﹤0.01% of J. Safra Asset Management's portfolio in Q2 2026, its #353 holding.
  • J. Safra Asset Management first reported a position in Revolution Medicines in Q4 2024 and has held it in 7 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on J. Safra Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.